While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors ...

Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock. Keep track of Cipla with the latest details, including: Last traded price ...

Catch up on the latest stock market updates!

The Indian Pharmaceuticals Market continued to deliver healthy growth at 8.7% year-on-year in January 2025, against 7.7% year ...

Despite conflicting international signals, the early Gift Nifty movement on Monday, February 10th, suggested a promising ...

VA Tech Wabag's shares soared 13.5% after the company announced winning a Rs 3,251 crore consortium order for the Al Haer ...

Indian pharma stocks experienced heavy selling on February 10, influenced by weak earnings and concerns over possible U.S.

The Indian pharmaceutical market (IPM) recorded an 8.7% year-on-year (YoY) growth in January 2025, reaching a monthly value ...

Stocks such as Natco, Dr. Reddy's, Cipla, Mankind, Torrent, Sun Pharma, Abbott, and Glenmark slipped in the range of 1-2 per ...

Fears regarding the potential for US President Trump to impose tariffs on pharmaceutical imports suppressed pharma stocks ...

The broader markets are trading in deeper red with the NSE Midcap and Smallcap indices slipping 1.5% and 1.8%, respectively ...

Trump's tariff news, FII selling, sanguine RBI policy, and rupee at record low dented investor sentiment today ...